CY1111286T1 - Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα - Google Patents

Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα

Info

Publication number
CY1111286T1
CY1111286T1 CY20101100802T CY101100802T CY1111286T1 CY 1111286 T1 CY1111286 T1 CY 1111286T1 CY 20101100802 T CY20101100802 T CY 20101100802T CY 101100802 T CY101100802 T CY 101100802T CY 1111286 T1 CY1111286 T1 CY 1111286T1
Authority
CY
Cyprus
Prior art keywords
bacteriophage
mediated immunity
designed
vaccines
phage
Prior art date
Application number
CY20101100802T
Other languages
English (en)
Inventor
John Bernard March
Original Assignee
Bigdna Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bigdna Ltd. filed Critical Bigdna Ltd.
Publication of CY1111286T1 publication Critical patent/CY1111286T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με εμβόλια που περιλαμβάνουν βακτηριοφάγο που έχει σχεδιαστεί ώστε να εκφράζει ανοσογόνο πρωτεΐνη/ πεπτίδιο και όπου η επιφάνεια του βακτηριοφάγου δεν έχει τροποποιηθεί για να περιέχει πρωτεΐνες/ πεπτίδια σχεδιασμένα για τη στόχευση του φάγου σε υποδοχείς στην επιφάνεια ειδικών κυτταρικών τύπων.
CY20101100802T 2001-03-23 2010-09-01 Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα CY1111286T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0107319.6A GB0107319D0 (en) 2001-03-23 2001-03-23 Bacteriophage-mediated immunisation
EP02720122A EP1370284B1 (en) 2001-03-23 2002-03-25 Bacteriophage-mediated immunisation

Publications (1)

Publication Number Publication Date
CY1111286T1 true CY1111286T1 (el) 2015-08-05

Family

ID=9911416

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100802T CY1111286T1 (el) 2001-03-23 2010-09-01 Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα

Country Status (13)

Country Link
US (1) US7128916B2 (el)
EP (1) EP1370284B1 (el)
JP (1) JP4653934B2 (el)
AT (1) ATE469655T1 (el)
AU (1) AU2002251192B2 (el)
CA (1) CA2441601C (el)
CY (1) CY1111286T1 (el)
DE (1) DE60236579D1 (el)
DK (1) DK1370284T3 (el)
ES (1) ES2345434T3 (el)
GB (1) GB0107319D0 (el)
PT (1) PT1370284E (el)
WO (1) WO2002076498A2 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222824D0 (en) * 2002-10-02 2002-11-06 Moredun Res Inst Bacteriophage-mediated immunisation II
EP1855723B1 (en) 2005-03-08 2013-05-22 Ramot at Tel-Aviv University Ltd. Targeted drug-carrying bacteriophages
WO2007076101A2 (en) * 2005-12-23 2007-07-05 Hygea Biopharma, Inc. Immunologically enhanced recombinant vaccines
JP2007204415A (ja) * 2006-02-01 2007-08-16 Tokyo Institute Of Technology ファージ頭殻提示腸管免疫誘導型ワクチン
GB0808780D0 (en) * 2008-05-15 2008-06-18 Big Dna Ltd Fish vaccines
WO2011045573A2 (en) 2009-10-15 2011-04-21 University Court Of The University Of Edinburgh Staphylococcal antigens
WO2011080505A2 (en) 2009-12-28 2011-07-07 Bigdna Ltd Method of growing phage for commercial use
GB201112587D0 (en) 2011-07-22 2011-09-07 Moredun Res Inst Vaccine
WO2014150870A2 (en) 2013-03-15 2014-09-25 Altria Client Services Inc. Bacteriophage and methods of making and using
WO2016123425A1 (en) 2015-01-29 2016-08-04 Altria Client Services Llc Endolysin from bacteriophage against geobacillus and methods of using
US9781929B2 (en) 2015-01-29 2017-10-10 Altria Client Services Llc Bacteriophage and methods of using
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
GB201600075D0 (en) * 2016-01-03 2016-02-17 Glaxosmithkline Biolog Sa Immunogenci composition
US20230218684A1 (en) * 2020-03-30 2023-07-13 North Carolina State University Engineered bacteria for use in vaccine compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736388A (en) 1994-12-30 1998-04-07 Chada; Sunil Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
AU3737297A (en) * 1996-08-05 1998-02-25 Brigham And Women's Hospital Bacteriophage-mediated gene therapy
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
CA2329908A1 (en) 1998-04-24 1999-11-04 The Regents Of The University Of California Targeted gene delivery to cells by filamentous bacteriophage
AU7572900A (en) * 1999-08-26 2001-03-19 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage

Also Published As

Publication number Publication date
EP1370284B1 (en) 2010-06-02
JP4653934B2 (ja) 2011-03-16
ATE469655T1 (de) 2010-06-15
US7128916B2 (en) 2006-10-31
WO2002076498A3 (en) 2003-08-14
WO2002076498A2 (en) 2002-10-03
ES2345434T3 (es) 2010-09-23
EP1370284A2 (en) 2003-12-17
CA2441601C (en) 2012-03-13
PT1370284E (pt) 2010-08-03
CA2441601A1 (en) 2002-10-03
DE60236579D1 (de) 2010-07-15
US20040121974A1 (en) 2004-06-24
GB0107319D0 (en) 2001-05-16
AU2002251192B2 (en) 2006-11-16
DK1370284T3 (da) 2010-09-27
JP2004525931A (ja) 2004-08-26

Similar Documents

Publication Publication Date Title
CY1111286T1 (el) Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα
CY1118037T1 (el) Αντισωματα εναντι του αβητα και h χρηση τους
UY28641A1 (es) Anticuerpos
ATE433491T1 (de) Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE458494T1 (de) Von der telomerase abgeleitete antigene peptide
CY1105616T1 (el) ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1
BRPI0418286A (pt) proteìnas de fusão de il-7
DK2316940T3 (da) Fokuserede biblioteker af genpakker
DE59813468D1 (de) Peptid mit radioprotektiver wirkung
CY1109140T1 (el) Τυποποιησεις εμβολιων που περιλαμβανουν αντιιδιοτυπικα αντισωματα τα οποια μιμουνται ανοσολογικα υαδατανθρακες των στρεπτοκοκκων ομαδας β
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
CY1106876T1 (el) Συσκευασια και μεθοδος ανιχνευσεως της πρωτεϊνης esm-1
CY1114526T1 (el) Κατασταλτικες πρωτεϊνες μιας πρωτεασης (protease) και χρησεις αυτων
CY1106433T1 (el) Εμβολια κοκκιδιωσης
ATE406449T1 (de) Antigene und vektoren für impfung
NZ535908A (en) HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
NZ515041A (en) Nucleic acid immunization
CU23164A3 (es) Proteina recombinante de union a aminas vasoactivas
ATE449611T1 (de) Bakteriophagen-vermittelte immunisierung gegen hepatitis
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
DK1117682T3 (da) Chi-conotoksin-peptider som inhibitorer af neuronale amintransportere
DE50304603D1 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze